Politics Versus Science in Biomedical Research and Development

Wechsler,Jill;

Publication

Article

July 2, 2004

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2004

Volume28

Issue 7

Politics Versus Science in Biomedical Research and Development

Author(s):

Jill Wechsler

Decisions to accelerate the approval of AIDS combination drugs, reject the over-the-counter status for the morning-after pill, and limit support for stem cell research are hot political topics.

External Link - article-103357.pdf

Articles in this issue

3M Drug Delivery Systems

AccuRate

July 2004

Characterization of the Performance of Bin Blenders Part 2 of 3: Free-Flowing Mixtures

Investors Shy Away from Pharmaceutical Chemicals

From CGMPs to the Critical Path: FDA Focuses on Innovation, Quality, and Continuous Improvement–Inside and Out

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Politics Versus Science in Biomedical Research and Development

Newsletter